IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q4 2024 Holdings

Filed 2025-02-07 | 25 holdings | $161.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$35.3M14,250,00022.0%
Ishares TR(SGOV)0-3 MNTH TREASRY46436E718$26.1M260,00016.2%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$25.5M7,608,31215.8%
Adverum Biotechnologies Inc(AVU0)COM NEW00773U207$10.6M2,268,0646.6%
An2 Therapeutics Inc(ANTX)COM037326105$7.9M5,749,4324.9%
Instil BIO Inc(TIL)COM NEW45783C200$7.6M400,0004.7%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$7.6M4,221,5464.7%
Aadi Bioscience Inc(WHWK)COM00032Q104$6.6M2,100,0004.1%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$6.4M2,643,9074.0%
Ikena Oncology IncCOM45175G108$5.9M3,585,8663.7%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$5.2M3,466,6843.3%
Achilles Therapeutics PLC(698)SPONSORED ADS00449L102$4.7M4,100,0022.9%
Connect Biopharma Hldgs LTDADS207523101$2.9M2,093,2321.8%
Milestone Pharmaceuticals in(MIST)COM59935V107$2.7M1,136,0911.7%
Athira Pharma IncCOM04746L104$1.6M2,775,8851.0%
Astrotech Corp(ASTC)COM046484309$1.5M220,4100.9%
Lisata Therapeutics Inc(LSTA)COM128058302$848.3K284,6690.5%
Palvella Therapeutics Inc NE(PVLA)COM697947109$505.6K42,1300.3%
Vistagen Therapeutics Inc(VTGN)COM92840H400$442.5K150,0000.3%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$327.0K48,6680.2%
Lenz Therapeutics Inc(LENZ)COM52635N103$267.7K9,2710.2%
Nextcure IncCOM65343E108$210.9K273,5360.1%
Verrica Pharmaceuticals IncCOM92511W108$122.3K174,6510.1%
Allovir IncCOM019818103$77.4K184,2460.0%
Hillevax IncCOM43157M102$43.0K20,7600.0%